1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 11th November 2024 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

Trial Report Advancing Therapeutics for Post-Viral ME/CFS and SFN in Long COVID: A 20- Week Sensomotoric Training Intervention, 2023, Ziaja et al

Discussion in 'ME/CFS research' started by Mij, Jan 2, 2024.

  1. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    9,576
    Advancing Therapeutics for Post-Viral ME/CFS and SFN in Long COVID: A 20- Week Sensomotoric Training Intervention

    Long COVID's (LC) emergence drives research and novel treatments for myalgic encefalitis ME/CFS. Sensomotoric-training's potential to regenerate ectodermal fibers offers hope for SFN patients. Research Focus: Long COVID's surge prompts innovative ME/CFS treatments targeting underlying causes. Sensomotoric-training's fiber regrowth potential could transform SFN management. Conclusion: Rising ME/CFS cases from Long COVID fuel research and therapeutic progress. Sensomotoric-training holds promise for SFN treatment. Exciting developments shape patient care.

    https://www.researchgate.net/public...Id=64db59b9ad846e288293e51c&showFulltext=true
     
    Last edited by a moderator: Jan 2, 2024
    Mij, Jan 2, 2024
    #1
    DokaGirl and oldtimer like this.
  2. MeSci

    MeSci Senior Member (Voting Rights)

    Messages:
    4,899
    Location:
    Cornwall, UK
    SFN is apparently Small Fiber Neuropathy (from downloaded PDF of the study).
     
    Last edited by a moderator: Jan 2, 2024
    MeSci, Jan 2, 2024
    #2
    MEMarge and DokaGirl like this.

Share This Page